Database: EUROCARE (European Union): Difference between revisions
(Created page with "{{forresearchers}} Go back to European Union page '''Primary purpose:''' To monitor cancer survival, measure cancer prevalence, and study patterns of care for cancer patients across Europe. [https://www.iss.it/en/eurocare-il-progetto Click here to learn more.] '''Sponsor, manager or home institution:''' dataOwner::the Istituto Nazionale dei Tumori (INT Milan) and the dataOwner::Istituto Superiore di Sanità (Rome). Patient-level data is owned by each indivi...") |
No edit summary |
||
| Line 18: | Line 18: | ||
'''Cancer Areas of Interest:''' [[hasCancerType::C00-C97: All cancer types]]. | '''Cancer Areas of Interest:''' [[hasCancerType::C00-C97: All cancer types]]. | ||
'''Data access:''' [[dataAvailability::publicly available]]. [https://eu5results.iss.it/forms/SA0007.aspx Click here to access]. Databases from previous editions of the EUROCARE study are also available. [https://www.iss.it/en/eurocare-database Click here to | '''Data access:''' [[dataAvailability::publicly available]]. [https://eu5results.iss.it/forms/SA0007.aspx Click here to access]. Databases from previous editions of the EUROCARE study are also available. [https://www.iss.it/en/eurocare-database Click here to access]. | ||
'''Contact information:''' [https://www.iss.it/en/eurocare-chi-siamo Click here to | '''Contact information:''' [https://www.iss.it/en/eurocare-chi-siamo Click here to access.] | ||
Revision as of 17:13, 29 April 2024
Go back to European Union page
Primary purpose: To monitor cancer survival, measure cancer prevalence, and study patterns of care for cancer patients across Europe. Click here to learn more.
Sponsor, manager or home institution: the Istituto Nazionale dei Tumori (INT Milan) and the Istituto Superiore di Sanità (Rome). Patient-level data is owned by each individual cancer registry. Click here to learn more.
Type of information: Cancer Site, Population, Age Class, ICSS - International Cancer Survival Standards, Time from Diagnosis, Sex, and Output Indicators including: Alive at Start, Observed Survival, Cumulative (OSC), Relative Survival, Cumulative (RSC), Relative SE's, Cumulative (RSEC), Dead, Expected Survival, Interval (ESI), Observed SE's, Interval (OSEI), RSC: Lower bound (95% CI), Lost to Follow Up, Expected Survival, Cumulative (ESC), Observed SE's, Cumulative (OSEC), RSC: Upper bound (95% CI), Observed Survival, Interval (OSI), Relative Survival, Interval (RSI), Relative SE's, Interval (RSEI).
Source of Information: 99 cancer registries from 29 countries participating in the study provided their patient-level data as of the 5th Edition of EUROCARE. Click here to learn more.
Data level: national level.
Number of Records: 9,000,000. Click here to learn more.
Date range: 2000 to 2007.
Cancer Areas of Interest: C00-C97: All cancer types.
Data access: publicly available. Click here to access. Databases from previous editions of the EUROCARE study are also available. Click here to access.
Contact information: Click here to access.
